China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHIFree Report) in a report issued on Tuesday morning. The firm issued a hold rating on the stock.

China Pharma Trading Up 7.5 %

Shares of China Pharma stock opened at $1.51 on Tuesday. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The stock’s fifty day moving average is $21.52 and its two-hundred day moving average is $21.57. China Pharma has a 52 week low of $1.20 and a 52 week high of $4.10.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

See Also

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.